The PACE program published a bulletin stating that effective July 1, 2026, PACE will recognize the Bridge program BIN as the primary payer for certain GLP-1 drugs when the Bridge program accepts and pays the claim.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.